Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

68
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
68
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

19.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Breaking the glial loop: astrocytic PAD2 and citrullinated vimentin drive microglial dysfunction in Alzheimer's disease.

Molecular neurodegeneration·2026
Same author

Discovery of a CI-994 derivative as a dual modulator of class I HDACs and Wnt/β- catenin signaling for Alzheimer's disease therapy.

bioRxiv : the preprint server for biology·2026
Same author

Alzheimer disease protection from the periphery.

Nature reviews. Neurology·2026
Same author

Association of plasma glial fibrillary acidic protein and APOE-ε4 with Alzheimer's disease.

Neurobiology of aging·2026
Same author

Astrocytic APOE3-Christchurch expression ameliorates brain amyloid-β pathology in 5xFAD mice.

Translational psychiatry·2026
Same author

Sex-specific APOE4-dependent innate immunity regulates meningeal lymphatics, brain lipids, neuroinflammation, and cognition.

Neuron·2026

Related Experiment Video

Updated: Mar 27, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.6K

A rapid and cost-effective method for genotyping apolipoprotein E gene polymorphism.

Li Zhong1, Yong-Zhuang Xie2, Tian-Tian Cao3

  • 1Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, Medical College, Xiamen University, Xiamen, 361102, China. zhongli1103@163.com.

Molecular Neurodegeneration
|January 13, 2016
PubMed
Summary

A new, accurate, and cost-effective APOE genotyping method using allele-specific PCR and TaqMan probes has been developed. This high-throughput assay accurately determines apolipoprotein E (ApoE) genotypes for disease risk assessment.

More Related Videos

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.3K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.8K

Related Experiment Videos

Last Updated: Mar 27, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.6K
High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

12.3K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.8K

Area of Science:

  • Genetics
  • Molecular Biology
  • Biochemistry

Background:

  • Apolipoprotein E (ApoE) is vital for lipid homeostasis in the periphery and brain.
  • Human APOE gene polymorphism (rs429358, rs7412) yields three alleles (ε2, ε3, ε4).
  • ApoE isoforms influence risk for vascular and neurodegenerative diseases, making APOE genotyping critical for personalized medicine.

Purpose of the Study:

  • To develop an accurate, cost-effective, and high-throughput method for APOE genotyping.
  • To validate the developed method against sequencing analysis for reliability.

Main Methods:

  • Developed an allele-specific PCR method adapted for Real-Time PCR using a single TaqMan probe.
  • Utilized site-specific PCR primers to recognize polymorphic alleles.
  • Assay completed within 90 minutes, suitable for high-throughput analysis.

Main Results:

  • Successfully genotyped 1158 human DNA samples with 100% concordance to sequencing analysis.
  • The developed APOE genotyping assay is accurate and cost-effective.
  • The method is applicable to large-scale sample genotyping.

Conclusions:

  • The novel APOE genotyping assay is accurate, cost-effective, and suitable for high-throughput analysis.
  • This method facilitates risk assessment for vascular and neurodegenerative diseases associated with APOE polymorphism.
  • Enables individualized therapy design based on APOE genotype.